Receive a free case review.
Novartis, a New Jersey based pharmaceutical company, manufactured
and marketed Zelnorm (also known as Tegaserod). The FDA approved Novartis to treat irritable bowel syndrome (IBS) in women in 2002 and to treat chronic idiopathic constipation (CIC) in 2004. Many lawsuits were filed after Novartis recalled Zelnorm because studies linked Zelnorm use to severe and fatal side effects including:
Zelnorm Lawsuits: Manufacturing an Unsafe Product
Victims injured by Zelnorm can file a lawsuit against Novartis for creating and marketing an unsafe drug. Many Zelnorm lawsuits allege that
|
Related Topics: |
Zelnorm lawsuits assert that several studies and reports link Zelnorm use to dangerous side effects, including:
Zelnorm Lawsuits: Failure to Warn
Zelnorm Lawsuits allege that Novartis failed to warn the public about Zelnorm side effects. Lawsuits claim that patients were using Zelnorm for almost two years before they were warned about the increased risk for ischemic colitis and severe diarrhea. Additionally, lawsuits note that Novartis warned health officials and the public about the increased risk for cardiovascular problems on March 30, 2007, more than a month after studies showed the increased risk (which occurred on February 22, 2007).
Information on Zelnorm Lawsuits
If you or a loved one has been injured by Zelnorm use, please contact us. You may have a legal right to file a lawsuit against Novartis. Recovery from a lawsuit may include:
Tegaserod